221 related articles for article (PubMed ID: 33965514)
1. Normal Tissue Complication Probability (NTCP) Prediction Model for Osteoradionecrosis of the Mandible in Patients With Head and Neck Cancer After Radiation Therapy: Large-Scale Observational Cohort.
van Dijk LV; Abusaif AA; Rigert J; Naser MA; Hutcheson KA; Lai SY; Fuller CD; Mohamed ASR;
Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):549-558. PubMed ID: 33965514
[TBL] [Abstract][Full Text] [Related]
2. Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations.
Aarup-Kristensen S; Hansen CR; Forner L; Brink C; Eriksen JG; Johansen J
Acta Oncol; 2019 Oct; 58(10):1373-1377. PubMed ID: 31364903
[No Abstract] [Full Text] [Related]
3. Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions.
Ben-David MA; Diamante M; Radawski JD; Vineberg KA; Stroup C; Murdoch-Kinch CA; Zwetchkenbaum SR; Eisbruch A
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):396-402. PubMed ID: 17321069
[TBL] [Abstract][Full Text] [Related]
4. Dental Extractions Before Radiation Therapy and the Risk of Osteoradionecrosis in Patients With Head and Neck Cancer.
Lee J; Hueniken K; Cuddy K; Pu J; El Maghrabi A; Hope A; Hosni A; Glogauer M; Watson E
JAMA Otolaryngol Head Neck Surg; 2023 Dec; 149(12):1130-1139. PubMed ID: 37856115
[TBL] [Abstract][Full Text] [Related]
5. Risk factors associated with the development of osteoradionecrosis (ORN) in Head and Neck cancer patients in Ireland: A 10-year retrospective review.
Fitzgerald KT; Lyons C; England A; McEntee MF; Devine A; O'Donovan T; O'Sullivan E
Radiother Oncol; 2024 Jul; 196():110286. PubMed ID: 38641259
[TBL] [Abstract][Full Text] [Related]
6. Is Dose Volume a Better Predictor of Osteoradionecrosis Risk Than Total Dose for Patients Who Have Received Head and Neck Radiation?
DeLuke D; Carrico C; Ray C; Stilianoudakis S; Holler S; Padilla L; Song S
J Oral Maxillofac Surg; 2022 Sep; 80(9):1557-1563. PubMed ID: 35594907
[TBL] [Abstract][Full Text] [Related]
7. Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy.
Caparrotti F; Huang SH; Lu L; Bratman SV; Ringash J; Bayley A; Cho J; Giuliani M; Kim J; Waldron J; Hansen A; Tong L; Xu W; O'Sullivan B; Wood R; Goldstein D; Hope A
Cancer; 2017 Oct; 123(19):3691-3700. PubMed ID: 28608925
[TBL] [Abstract][Full Text] [Related]
8. Factors predictive of severity of osteoradionecrosis of the mandible.
Chopra S; Kamdar D; Ugur OE; Chen G; Peshek B; Marunick M; Kim H; Lin HS; Jacobs J
Head Neck; 2011 Nov; 33(11):1600-5. PubMed ID: 21484922
[TBL] [Abstract][Full Text] [Related]
9. Development of a local dose-response relationship for osteoradionecrosis within the mandible.
Sijtsema ND; Verduijn GM; Nasserinejad K; van Norden Y; Mast H; van der Lugt A; Hoogeman MS; Petit SF
Radiother Oncol; 2023 Sep; 186():109736. PubMed ID: 37315578
[TBL] [Abstract][Full Text] [Related]
10. Do pre-irradiation dental extractions reduce the risk of osteoradionecrosis of the mandible?
Chang DT; Sandow PR; Morris CG; Hollander R; Scarborough L; Amdur RJ; Mendenhall WM
Head Neck; 2007 Jun; 29(6):528-36. PubMed ID: 17230555
[TBL] [Abstract][Full Text] [Related]
11. Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer.
Tsai CJ; Hofstede TM; Sturgis EM; Garden AS; Lindberg ME; Wei Q; Tucker SL; Dong L
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):415-20. PubMed ID: 22795804
[TBL] [Abstract][Full Text] [Related]
12. Exposed bone in patients with head and neck cancer treated with radiation therapy: An analysis of the Observational Study of Dental Outcomes in Head and Neck Cancer Patients (OraRad).
Treister NS; Brennan MT; Sollecito TP; Schmidt BL; Patton LL; Mitchell R; Haddad RI; Tishler RB; Lin A; Shadick R; Hodges JS; Lalla RV
Cancer; 2022 Feb; 128(3):487-496. PubMed ID: 34665873
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and dose-effect relationship for mandibular osteoradionecrosis in oral and oropharyngeal cancer patients.
Lee IJ; Koom WS; Lee CG; Kim YB; Yoo SW; Keum KC; Kim GE; Choi EC; Cha IH
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1084-91. PubMed ID: 19327914
[TBL] [Abstract][Full Text] [Related]
14. Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer.
Gomez DR; Estilo CL; Wolden SL; Zelefsky MJ; Kraus DH; Wong RJ; Shaha AR; Shah JP; Mechalakos JG; Lee NY
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e207-13. PubMed ID: 21570202
[TBL] [Abstract][Full Text] [Related]
15. Osteoradionecrosis.
O'Dell K; Sinha U
Oral Maxillofac Surg Clin North Am; 2011 Aug; 23(3):455-64. PubMed ID: 21798443
[TBL] [Abstract][Full Text] [Related]
16. [Mandibular osteoradionecrosis (ORN) as a side effect of head and neck cancer treatment: Factors that induce it].
Gallegos-Hernández JF; Reyes-Vivanco A; Arias-Ceballos H; Minauro-Muñoz GG; Ortiz-Maldonado AL; García-Ruiz DI; Hernández-Sanjuán M
Gac Med Mex; 2016; 152(6):730-733. PubMed ID: 27861470
[TBL] [Abstract][Full Text] [Related]
17. Osteoradionecrosis of the mandible: minimized risk profile following intensity-modulated radiation therapy (IMRT).
Studer G; Studer SP; Zwahlen RA; Huguenin P; Grätz KW; Lütolf UM; Glanzmann C
Strahlenther Onkol; 2006 May; 182(5):283-8. PubMed ID: 16673062
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy-induced mandibular bone complications.
Jereczek-Fossa BA; Orecchia R
Cancer Treat Rev; 2002 Feb; 28(1):65-74. PubMed ID: 12027415
[TBL] [Abstract][Full Text] [Related]
19. Osteoradionecrosis of mandible bone in patients with oral cancer--associated factors and treatment outcomes.
Chen JA; Wang CC; Wong YK; Wang CP; Jiang RS; Lin JC; Chen CC; Liu SA
Head Neck; 2016 May; 38(5):762-8. PubMed ID: 25521838
[TBL] [Abstract][Full Text] [Related]
20. Osteoradionecrosis after postoperative radiotherapy for oral cavity cancer: A retrospective cohort study.
Möring MM; Mast H; Wolvius EB; Verduijn GM; Petit SF; Sijtsema ND; Jonker BP; Nout RA; Heemsbergen WD
Oral Oncol; 2022 Oct; 133():106056. PubMed ID: 35933938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
